Bancreek Global Select ETF
BCGS - ETF AI Analysis
Top Page
Bancreek Global Select ETF (BCGS)
BCGS, the Bancreek Global Select ETF, has a solid overall rating driven mainly by high-quality holdings like Cintas, Meta Platforms, Visa, and Williams-Sonoma, which show strong financial performance, positive earnings sentiment, and strategic initiatives in areas like AI and innovation. These strengths are partly offset by weaker names such as Sigma Healthcare and Amneal Pharmaceuticals, where profitability, cash flow, or valuation concerns are more pronounced, and by a general risk that several holdings show bearish or mixed technical momentum, which can add short-term volatility.
BCGS vs. SPDR S&P 500 ETF (SPY)
- AUM
- 36.96M
- Region
- Global
- Expense Ratio
- 0.80%
- Beta
- 1.12
- Issuer
- Bancreek
- Inception Date
- Mar 09, 2026
- Dividend Yield
- 0.52%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
BCGS Summary
Bancreek Global Select ETF (BCGS) is a global large‑cap fund that uses a rules-based, quantitative approach instead of tracking a traditional index. It invests in big companies across many countries, mainly the U.S., with added exposure to markets like South Korea, Japan, and the UK. The fund spreads money across sectors such as industrials, technology, and consumer companies, and holds well-known names like Dell Technologies and Broadcom. Investors might consider BCGS for diversified growth across global large companies. A key risk is that its stock and convertible holdings can rise or fall with overall market conditions worldwide.
How much will it cost me?
This ETF has an expense ratio of 0.80%, which means you’ll pay about $8 per year for every $1,000 you invest. That’s higher than the average ETF cost because it’s actively managed using a quantitative strategy rather than simply tracking a broad market index.
What would affect this ETF?
This global large-cap ETF could benefit if worldwide economic growth stays steady, industrial and technology spending remains strong, and its quantitative stock-picking continues to identify companies that grow earnings over time. On the other hand, a global slowdown, rising interest rates that pressure growth stocks, or sector-specific setbacks in industrials and technology—where the fund has meaningful exposure—could weigh on performance, as could market volatility in the developed and emerging markets it invests in.
BCGS Top 10 Holdings
Bancreek Global Select leans into a quirky mix of global large caps rather than the usual Big Tech suspects. Victory Capital has been a quiet engine for the fund, steadily climbing and giving financials a small but powerful boost. Consumer names like Brinker International and Dollarama are also pulling their weight, helping cyclical exposure shine. On the flip side, AppLovin and Rollins look more like dead weight this year, with earlier momentum losing steam. With holdings spread across the U.S., Canada, Europe, and beyond, the ETF feels global but not overly tied to any single sector or country.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| AppLovin | 3.03% | $1.14M | $134.11B | -32.69% | 74Outperform | |
| Carvana Co | 2.50% | $938.52K | $81.50B | 7.93% | 66Neutral | |
| Victory Capital Holdings | 2.36% | $887.72K | $7.77B | 95.81% | 80Outperform | |
| Spotify | 2.36% | $886.27K | $125.41B | -7.62% | 66Neutral | |
| Rollins | 2.35% | $883.43K | $18.39B | -35.17% | 79Outperform | |
| Tapestry | 2.31% | $868.44K | $26.20B | 27.55% | 69Neutral | |
| Ubiquiti Networks | 2.29% | $859.47K | $41.09B | 16.83% | 60Neutral | |
| Amneal Pharmaceuticals | 2.23% | $837.79K | $7.56B | 82.35% | 58Neutral | |
| SK Square Co., Ltd. | 2.18% | $818.08K | KRW 104.79T | 145.27% | ―― | |
| Howmet Aerospace | 2.16% | $810.43K | $89.08B | 8.80% | 67Neutral |
BCGS Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BCGS, the sentiment is Neutral. The current price of 24.80 is below the 20-day moving average (MA) of 24.87, below the 50-day MA of 26.11, and compared to the 200-day MA of , indicating a neutral trend. The MACD of -0.46 indicates Negative momentum. The RSI at 46.17 is Neutral, neither overbought nor oversold. The STOCH value of 81.11 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for BCGS.
BCGS Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $24.80 | $27.00(8.89% Upside) | $36.96M | 0.80% | 63Neutral | |
| $46.56 | $55.28(18.74% Upside) | $51.89M | 0.35% | 65Neutral | |
| $27.46 | $31.89(16.15% Upside) | $40.59M | 0.62% | 62Neutral | |
| $31.46 | $41.39(31.56% Upside) | $21.61M | 0.69% | 72Outperform | |
| $56.59 | $67.95(20.08% Upside) | $12.64M | 0.47% | 66Neutral | |
| $25.97 | $32.37(24.62% Upside) | $9.63M | 0.75% | 72Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| BCGS | Bancreek Global Select ETF | 24.80 | -0.45 | -1.78% | |
| NTSD | WisdomTree Efficient U.S. Plus International Equity Fund | 46.55 | 7.68 | 19.76% | |
| OAKG | Oakmark Global Large Cap ETF | 27.45 | 1.70 | 6.62% | |
| GPT | Intelligent Alpha Atlas ETF | 31.46 | 1.53 | 5.10% | |
| JDIV | JPMorgan Dividend Leaders ETF | 56.59 | 4.39 | 8.41% | |
| BCGD | Baron Global Durable Advantage ETF | 25.97 | 0.79 | 3.12% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
